News Focus
News Focus
icon url

cjstocksup

11/09/12 12:16 PM

#6770 RE: Carter #6767

AMARANTUS BIOSCIENCES INC(OTC:AMBS) The Company has appointed Amgen Co-Founder Joseph Rubinfeld, PhD to its Corporate Advisory Board. Dr. Rubinfeld will assist management in positioning the Company's development programs for partnering, as well as provide guidance on MANF-based small molecule strategies with his extensive medicinal chemistry background.The Company is a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF.
icon url

cjstocksup

11/09/12 12:17 PM

#6771 RE: Carter #6767

Dr. Rubinfeld: "...I believe that MANF could be one of the biggest successes that I have ever seen." From: http://www.sbwire.com/press-releases/amarantus-biosciences-inc-otc-ambs-what-a-stock-178166.htm

Guys, we have a tiger by the tail, no matter how you slice it. AMBS